Rapid Fire Marketing (RPDM) 10-Q 14 May 15 2015 Q1 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	3 Months Ended
	Mar. 31, 2015	6-May-15
Document And Entity Information [Abstract]
Entity Registrant Name	RAPID FIRE MARKETING, INC.
Entity Central Index Key	859917
Document Type	10-Q
Document Period End Date	31-Mar-15
Amendment Flag	FALSE
Current Fiscal Year End Date	-19
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		7,466,034,776
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2015

Balance_Sheets_Unaudited

Balance Sheets (Unaudited) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Assets:
Cash and cash equivalents	$26,642	$4,430
Accrued interest	63,136	52,179
Inventory	40,168	40,373
Deposit on inventory	104,000	104,000
Prepaid expense		22,500
Current assets	233,946	223,482
Total assets	233,946	223,482
Current liabilities
Accounts payable and accrued liabilities	756,308	670,959
Convertible notes payable, net discount of $27,100 and $25,767	61,650	112,733
Derivative liabilities	215,907	177,323
Current liabilities	1,033,865	961,015
Total liabilities	1,033,865	961,015
Commitments and contingencies
Stockholders' Equity (Deficit):
Common Stock,$0.001 par value 20,000,000,000 shares authorized, 6,539,404,848 and 4,960,208,217 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively. 2,856,694,932 shares reserved for issuance at March 31, 2015	6,539,407	4,960,208
Stock to be issued	1,309,906	1,014,906
Additional paid-in capital	20,954,829	22,094,591
Stock subscription receivable	-5,416,000	-5,516,000
Accumulated deficit	-24,206,856	-23,310,033
Total stockholders' deficit	-799,919	-737,533
Total liabilities and stockholders' deficit	233,946	223,482
Series A1 Convertible Preferred stock [Member]
Stockholders' Equity (Deficit):
Preferred Stock	2,790	2,790
Series A2 Convertible Preferred stock [Member]
Stockholders' Equity (Deficit):
Preferred Stock
Series B Preferred Stock [Member]
Stockholders' Equity (Deficit):
Preferred Stock	16,000	16,000
Series C Preferred Stock [Member]
Stockholders' Equity (Deficit):
Preferred Stock	$5	$5

Balance_Sheets_Parenthetical

Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Debt Instrument, Unamortized Discount	$27,100	$25,767
Preferred Stock, Shares Authorized	90,000,000
Common Stock, Par Value	$0.00	$0.00
Common Stock, Shares Authorized	20,000,000,000	20,000,000,000
Common Stock, Shares Issued	6,539,404,848	4,960,208,217
Common Stock, Shares Outstanding	6,539,404,848	4,960,208,217
Common Stock, Capital Shares Reserved for Future Issuance	2,856,694,932
Series A1 Convertible Preferred stock [Member]
Preferred Stock, Par Value	$0.00	$0.00
Preferred Stock, Shares Authorized	25,000,000	25,000,000
Preferred Stock, Shares Issued	2,790,000	2,790,000
Preferred Stock, Shares Outstanding	2,790,000	2,790,000
Series A2 Convertible Preferred stock [Member]
Preferred Stock, Par Value	$0.00	$0.00
Preferred Stock, Shares Authorized	300	300
Preferred Stock, Shares Issued	95	125
Preferred Stock, Shares Outstanding	95	125
Common Stock, Capital Shares Reserved for Future Issuance	263,607,842
Series B Preferred Stock [Member]
Preferred Stock, Par Value	$0.00	$0.00
Preferred Stock, Shares Authorized	16,000,000	16,000,000
Preferred Stock, Shares Issued	16,000,000	16,000,000
Preferred Stock, Shares Outstanding	16,000,000	16,000,000
Series C Preferred Stock [Member]
Preferred Stock, Par Value	$0.00	$0.00
Preferred Stock, Shares Authorized	5,000	5,000
Preferred Stock, Shares Issued	5,000	5,000
Preferred Stock, Shares Outstanding	5,000	5,000

Statements_of_Operations_Unaud

Statements of Operations (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income Statement [Abstract]
Sales	$663	$859
Costs of sales	727	681
Gross profit (loss)	-64	178
Operating expenses:
Sales and marketing	52,051	20,692
General and administrative	119,908	233,708
Stock for services	42,500	50,737
Total operating expenses	214,459	305,137
Loss from operations	-214,523	-304,959
Other income (expense)
Interest income	13,326	2,453
Interest expense	-181,007	-28,486
Day one charge and change in fair value of derivative liabilities	11,416	-1,671,958
Loss on common shares issued	-526,035	-4,478,824
Total other income (expense)	-682,300	-6,176,815
Net loss before income taxes	-896,823	-6,481,774
Provision for income taxes
Net loss	($896,823)	($6,481,774)
Basic net loss per share	$0	$0
Diluted net loss per share	$0	$0
Basic weighted average number of shares of common stock outstanding	5,946,457,037	2,852,173,398
Diluted weighted average number of shares of common stock outstanding	5,946,457,037	2,852,173,398

Statements_of_Cash_Flows_Unaud

Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	($896,823)	($6,481,774)
Adjustments to reconcile net loss to net cash used in operating activities:
Day one charge and loss on change in fair market value of derivative liabilities	-11,416	1,671,958
Common stock issued for services and stock based compensation	65,000	50,737
Fair market value of common stock issued in connection with Series A preferred stock dividends	425,331	4,478,824
Amortization of discount on convertible notes payable	54,917	24,018
On issuance discount on convertible notes payable		10,000
Loss on shares issued in excess of liabilities settled	100,704
Changes in operating assets and liabilities:
Accrued interest receivable	-10,957	2,011
Prepaid expenses
Inventory	205	182
Accounts payable and accrued liabilities	145,251	-8,544
Net cash used in operating activities	-127,788	-252,588
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from convertible notes payable	50,000	100,000
Proceeds received from stock subscription	100,000	300,495
Net cash provided by financing activities	150,000	400,495
Change in cash and cash equivalents	22,212	147,907
Cash and cash equivalents, beginning of period	4,430	2,351
Cash and cash equivalents, end of period	26,642	150,258
Supplemental disclosures of cash flow information:
Cash paid for interest
Cash paid for income taxes
Non-cash investing and financing activities:
Conversion of notes payable and accrued interest to common stock	89,882
Conversion of preferred stock into common stock	300,000	250,000
Conversion of accounts payable into convertible note		82,500
Issuance of common stock accounted for as deferred offering costs		88,757
Increase in subscription receivable		5,000,000
Discount on convertible notes payable, including OID	$56,250	$192,500

Organization_and_Description_o

Organization and Description of Business	3 Months Ended
	Mar. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Note 1 - Organization and Description of Business
	Rapid Fire Marketing, Inc. (the “Company” or “RFMK”) was incorporated under the laws of the state of Delaware in 1989 as G.D.E. Search Corporation. In 2001, the Company changed its name to N-Vision Technology. In July 2007, the Company changed its name to Rapid Fire Marketing, Inc.
	The Company is a developer and reseller of herbal vaporizers. The core strategy is to maximize revenues in the rapidly expanding vaporizer industry. The Company currently sells the CANNAcig and Cumulus personal vapor inhalers. Beginning in February of 2013, the Company began developing a dry herbal vaporizer. The dry herbal vaporizer was in development and testing as of the end of June 30, 2014 and is expected to be available by early to mid 2015.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 - Summary of Significant Accounting Policies
	The financial statements included herein, presented in accordance with United States generally accepted accounting principles and stated in US dollars, have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading.
	These statements reflect all adjustments, consisting of normal recurring adjustments, which, in the opinion of management, are necessary for fair presentation of the information contained therein. It is suggested that these interim financial statements be read in conjunction with the financial statements and notes thereto for the Company for the year ended December 31, 2014 included in the Company’s Annual Report on Form 10-K. The financial statements for the three months ended March 31, 2015 are not necessarily indicative of the results expected for the year ending December 31, 2015.
	Going Concern
	The Company has limited working capital, has incurred losses in each of the past two years, and has not yet received material revenues from sales of products or services. These factors create substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern.
	The ability of RFMK to continue as a going concern is dependent on the Company generating cash from the sale of its common stock and/or obtaining debt financing and attaining future profitable operations. During the three months ended March 31, 2015, the Company funded operations through the receipt of $50,000 in net proceeds from convertible notes payable and $100,000 in connection with proceeds received in connection with the sale of Series A2 Convertible Preferred stock. As of March 31, 2015, the Company has subscriptions receivable from sales of Series A2 Convertible Preferred stock and Series C Convertible Preferred stock of $500,000 and $4,950,000, respectively. Subsequent to quarter end, the Company has received $50,000 in proceeds related to Series A2 Convertible Preferred stock. Management’s plans include collecting on the remaining sales of Series A2 Convertible Preferred stock and Series C Convertible Preferred stock, selling its equity securities and obtaining debt financing to fund its capital requirement and ongoing operations; however, there can be no assurance the Company will be successful in these efforts.
	The financial statements have been prepared on a going concern basis which contemplates the realization of assets and the settlement of liabilities in the normal course of business. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets and liabilities that might result from the outcome of this uncertainty.
	Risks and Uncertainties
	The Company has a limited operating history and has not generated significant revenues from our planned principal operations.
	The Company’s business and operations are sensitive to general business and economic conditions in the U.S. and worldwide. These conditions include short-term and long-term interest rates, inflation, fluctuations in debt and equity capital markets and the general condition of the U.S. and world economy. A host of factors beyond the Company’s control could cause fluctuations in these conditions, including the political environment and acts or threats of war or terrorism. Adverse developments in these general business and economic conditions, including through recession, downturn or otherwise, could have a material adverse effect on the Company’s financial condition and the results of its operations.
	The Company currently has minimal sales and limited marketing and/or distribution capabilities. The Company has limited experience in developing, training or managing a sales force and will incur substantial additional expenses if we decide to market any of our current and future products. Developing a marketing and sales force is also time consuming and could delay launch of our future products. In addition, the Company will compete with many companies that currently have extensive and well-funded marketing and sales operations. Our marketing and sales efforts may be unable to compete successfully against these companies. In addition, the Company has limited capital to devote sales and marketing.
	The Company’s industry is characterized by rapid changes in technology and customer demands. As a result, the Company’s products may quickly become obsolete and unmarketable. The Company’s future success will depend on its ability to adapt to technological advances, anticipate customer demands, develop new products and enhance our current products on a timely and cost-effective basis. Further, the Company’s products must remain competitive with those of other companies with substantially greater resources. The Company may experience technical or other difficulties that could delay or prevent the development, introduction or marketing of new products or enhanced versions of existing products. Also, the Company may not be able to adapt new or enhanced products to emerging industry standards, and the Company’s new products may not be favorably received. Nor may we have the capital resources to further the development of existing and/or new ones.
	The Company’s operations are subject to new innovations in product design and function. Significant technical changes can have an adverse effect on product lives. Design and development of new products are important elements to achieve and maintain profitability in the Company’s industry segment. The Company may be subject to federal, state and local environmental laws and regulations. The Company does not anticipate expenditures to comply with such laws and does not believe that regulations will have a material impact on the Company’s financial position, results of operations, or liquidity. The Company believes that its operations comply, in all material respects, with applicable federal, state, and local environmental laws and regulations
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
	Inventory
	Inventory consists of two finished products, the CANNAcig Vapor Inhaler and the Cumulus Vapor Inhaler, which are valued at the lower of cost or market valuation under the first-in, first-out method of costing. In addition, deposits on inventory consist of monies advanced to the contract manufacturer in connection with the production of our new dry herbal vaporizer which expected to be put into production in early 2015 to be delivered in mid 2015.
	Product obsolescence may be caused by changes in technology, discontinuance of a product line, replacement products in the marketplace or other competitive situations. The Company maintains a reserve on inventories that are considered to be slow moving or obsolete, to reduce the inventory to their net estimated realizable value. Once specific inventory is written-down, the write-down is permanent until the inventory is physically disposed of.
	Revenue Recognition
	The Company generates revenue from the product sales of the CANNAcig Vapor Inhaler and the Cumulus Vapor Inhaler product sales of Bionic cigarettes revenue is recognized when the purchase is complete and shipment has occurred. Shipping and handling fees and costs incurred are included as an offset to general and administrative expenses. The amount of revenue received for shipping and handling is less than 5% of revenues for all periods presented. Sales tax collected from customers is not recorded as revenue. Sales tax collected is included in accounts payable until remitted to the taxing authorities.
	Research and Development
	All research and development costs, including licensing costs, are charged to expense as incurred. In accordance with this policy, all costs associated with the design, development and testing of the Company’s products have been expensed as incurred.
	Fair Value of Financial Instruments
	The Company follows Accounting Standards Codification (“ASC”) 825 Fair Value Measurements and Disclosures, except as it applies to the nonfinancial assets and nonfinancial liabilities subject to ASC 825. ASC 825 clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. As a basis for considering such assumptions, ASC 825 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:
	Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
	Level 2 - Include other inputs that are directly or indirectly observable in the marketplace.
	Level 3 - Unobservable inputs which are supported by little or no market activity.
	Fair-value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of March 31, 2015 and December 31, 2014. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values. These financial instruments include cash, prepaids, accounts payable, accrued liabilities, and convertible notes payable. Fair values for these items were assumed to approximate carrying values because of their short term nature or because they are payable on demand. As of March 31, 2015 and December 31, 2014, the Company’s derivative liabilities were considered Level 2. See Note 3 for discussion regarding the determination of the fair market value.
	Earnings (loss) Per Share
	Basic earnings (loss) per share are computed by dividing the net income (loss) by the weighted-average number of shares of common stock and common stock equivalents (primarily outstanding shares of convertible debt, preferred stock, options and warrants). Common stock equivalents represent the dilutive effect of the assumed exercise of the outstanding stock options and warrants, using the treasury stock method. The calculation of fully diluted earnings (loss) per share assumes the dilutive effect of the exercise of outstanding convertible debt, preferred stock, options and warrants at either the beginning of the respective period presented or the date of issuance, whichever is later. As of March 31, 2015 and 2014, the Company’s dilutive securities consisted of convertible notes payable and Series A1, Series A2 and Series C preferred stock. If the holders of the convertible notes payable, Series A1 Preferred Stock, Series A2 Preferred Stock and Series C Preferred Stock all converted, the Company would be in excess of their authorized shares. The outstanding dilutive securities have been excluded from the calculation of diluted net loss per share because the effect would have been anti-dilutive for the three months ended March 31, 2015 and 2014.

Convertible_Notes_Payable_and_

Convertible Notes Payable and Derivative Liabilities	3 Months Ended
	Mar. 31, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Convertible Notes Payable and Derivative Liabilities	Note 3 - Convertible Notes Payable and Derivative Liabilities
	As of January 28, 2014, the Company had incurred amounts of $82,500 owed to Pyrenees Investments, LLC for service rendered. On January 28, 2014, the indebtedness was sold to Iconic Holdings, LLC, a third party. In connection with this sale, the Company issued a $82,500 convertible note to the third party. The convertible note incurs interest at 10% per annum and is due January 24, 2015. If a default is called by the lender after failure to repay principal or interest when due, among other default provisions including untimely filings with the SEC, a default interest rate of 20% per annum is triggered and retrospectively applied from the note’s inception date on the unpaid amount, and in addition the principal balance is increased by 150% of the face amount of the note deemed in default. At any time the note may be converted into shares of common stock, at the lower of $0.0006 or 50% discount off the lowest trading price for the Company’s common stock within the twenty (20) days preceding the conversion. The Company recorded a discount totaling $82,500 related to the beneficial conversion feature embedded in the note upon issuance. See below for discussion of derivative liabilities related to the conversion feature due to the absence of a conversion floor. In connection with this agreement, the Company reserved 250,000,000 shares of its common stock with the transfer agent. As of March 31, 2015 and December 31, 2014, the principal balance of the note was $0 and $57,500, respectively.
	In January 2014, the Company entered into a $165,000 convertible note agreement with Iconic Holdings. Under the terms of the agreement the Company was to receive $150,000, in proceeds. The Company received proceeds of $100,000 in February 2014, $25,000 in October 2014, and $25,000 February 2015 resulting in a total on issuance discount of $15,000. The convertible note incurs interest at 10% per annum and was due January 28, 2015. If a default is called by the lender after failure to repay principal or interest when due, among other default provisions including untimely filings with the SEC, a default interest rate of 20% per annum is triggered and retrospectively applied from the note’s inception date on the unpaid amount, and in addition the principal balance is increased by 150% of the face amount of the note deemed in default. At any time the note may be converted into common stock, at the lower of $0.0006 or 50% discount off the lowest trading price for the Company’s common stock within the twenty (20) days preceding the conversion. The Company recorded a discount totaling $165,000, which included $15,000 for the on issuance discount, related to the beneficial conversion feature embedded in the note upon issuance. See below for discussion of derivative liabilities related to the conversion feature due to the absence of a conversion floor. In connection with this agreement, the Company reserved 250,000,000 shares of its common stock with the transfer agent. As of March 31, 2015 and December 31, 2014, the principal balance of the note was $5,000 and $30,000, respectively.
	In March 2015, the Company entered into a $230,000 convertible note agreement with Iconic Holdings. Under the terms of the agreement the Company was to receive $200,000, in proceeds. The Company received $25,000 in proceeds in March 2015 resulting in an on issuance discount of $3,750. The convertible note incurs interest at 10% per annum and is due March 10, 2015. If a default is called by the lender after failure to repay principal or interest when due, among other default provisions including untimely filings with the SEC, a default interest rate of 20% per annum is triggered and retrospectively applied from the note’s inception date on the unpaid amount, and in addition the principal balance is increased by 150% of the face amount of the note deemed in default. At any time the note may be converted into common stock, at a 50% discount off the lowest trading price for the Company’s common stock within the twenty five (25) days preceding the conversion. The Company recorded a discount totaling $28,750, which included $3,750 for the on issuance discount, related to the beneficial conversion feature embedded in the note upon issuance. See below for discussion of derivative liabilities related to the conversion feature due to the absence of a conversion floor. As of March 31, 2015, the principal balance of the note was $28,750.
	During the three months ended March 31, 2015, the holder converted $82,500 of principal and $7,382 of accrued interest into 831,755,454 shares of common stock. In addition, during the three months ended March 31, 2015 and 2014, $54,917 and $24,018 of the convertible note discounts were amortized to interest expense, respectively. As of March 31, 2015, discounts of $27,100 remain and will be amortized within the year ended December 31, 2015.
	Derivative Liabilities
	The Company calculated the derivative liability using the Black-Scholes pricing model for each note upon inception and recorded the fair market value of the derivative liability as a discount to the note. When a derivative liability associated with a convertible note is in excess of the face value of the convertible note, the excess of fair value of derivative is charged to the statement of operations.
	During the three months ended March 31, 2015, the Company received proceeds of $50,000 from convertible debt with principal stated amounts of $56,250. At the inception of these notes, they were fully discounted due to value of the associated derivative liabilities. In addition, due to the value of the derivative liabilities being in excess of the principal stated amount a day one charge of $124,041 was recorded
	Aggregate derivative liabilities associated with remaining convertible notes were $215,907 as of March 31, 2015. Based on this revaluation at quarter end the Company recognized a loss (gain) in the change of fair value of derivative liability of ($135,437) and $674,996 during the three months ended March 31, 2015 and 2014, respectively.
	The following are the weighted average variable used in determining the fair market value of the Company’s derivative liabilities:
	Date	9-Feb-15			10-Mar-15			31-Mar-15
	Closing stock price of common stock	$	0.0005		$	0.0004		$	0.0003
	Conversion price	$	0.0002		$	0.0001		$	0.0001
	Expected life in years		0.5			1			0.50 to 0.90
	Risk free rate		0.11	%		0.11	%		0.03	%
	Expected annual volatility		247	%		221	%		215% to 247%
	Dividend percentage		0	%		0	%		0	%

Subscriptions_Receivables

Subscriptions Receivables	3 Months Ended
	Mar. 31, 2015
Receivables [Abstract]
Subscriptions Receivables	Note 4 - Subscriptions Receivables
	As of March 31, 2015, the Company held nine (9) notes receivable (the “Series A2 Notes”) from Ironridge Global IV, Ltd totaling $450,000 related to the sale of Series A2 Convertible Preferred Stock (see below for rights and preferences). The principal balance outstanding under the Series A2 Notes bears interest at the rate of 1.0% per annum. The entire unpaid principal balance, interest and any other charges due and payable under these Series A2 Notes will become due and payable 29 months from the date of issuance (September 21, 2012) and is recorded as a reduction to Stockholders’ Equity on the accompanying balance sheet. The Series A2 Notes shall be deemed not due and payable should the Company not have either 1) a registration statement on file and effective with the SEC covering the underlying common shares issuable as a result of the preferred shares, or 2) that the underlying common shares are eligible for trading under the then current Rule 144 as promulgated by the Securities of Act of 1933, as amended. The Company is also required to maintain adequate coverage of authorized shares, and must have the ability to issue common shares to the holder of the preferred shares in electronic format. Other customary events of default also apply. During the three months ended March 31, 2015 and 2014, the Company received $100,000 and $250,000 in proceeds related to the payment of the Series A2 Notes and recorded interest income of $13,326 and $2,453, respectively. In addition, subscription receivables includes $16,000 in excess common stock in which was issued to the holders of Series A2 Notes which needs to be remitted by the holder.
	On March 27, 2014, the Company entered into an agreement with the same party discussed above for the issuance of 100 notes receivable (the “Series C Notes”) from one issuer totaling $5,000,000 related to the sale of Series C Convertible Preferred Stock (see below for rights and preferences). The principal balance outstanding under the Series C Notes bears interest at the rate of 1.0% per annum. The entire unpaid principal balance, interest and any other charges due and payable under these Series C Notes will become due and payable 82 weeks from the date of issuance and is recorded as a reduction to Stockholders’ Equity on the accompanying balance sheet. The Series C Notes deemed not due and payable should the Company not have either 1) a registration statement on file and effective with the SEC covering the underlying common shares issuable as a result of the preferred shares, or 2) that the underlying common shares are eligible for trading under the then current Rule 144 as promulgated by the Securities of Act of 1933, as amended. The Company is also required to maintain adequate coverage of authorized shares, and must have the ability to issue common shares to the holder of the preferred shares in electronic format. Other customary events of default also apply. As of March 31, 2015, $4,950,000 of the Series C Notes balance remained unpaid. During the three months ended March 31, 2015 and 2014, the Company received $0 and $50,000 in proceeds related to the payment on the Series C Notes. Additional, proceeds are dependent upon the Company maintaining sufficient authorized shares.

Stockholders_Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2015
Equity [Abstract]
Stockholders' Equity	Note 5 - Stockholders’ Equity
	Preferred Stock
	Series A1 Preferred Stock
	On September 6, 2011, the Company filed a Certificate of Designation of Series A1 Convertible Preferred Stock (“Series A1”) with the Secretary of State of Nevada. Pursuant to the Series A1 Certificate of Designation, the Company designated 25,000,000 shares of its blank check preferred stock as Series A1 Preferred Stock. The Series A1 Preferred Stock ranks senior to the common stock (the “Junior Stock”). The Series A1 Preferred Stock can be converted at anytime into 30 common shares per one preferred share. In the event of a liquidation, the Series A1 Preferred Stock will be entitled to a liquidation at the same as common stock. The Series A1 Preferred Stock has no voting rights.
	Series A2 Preferred Stock
	On October 5, 2012, the Company filed a Certificate of Designation of Series A2 Convertible Preferred Stock (“Series A2”) with the Secretary of State of Nevada. Pursuant to the Series A2 Certificate of Designation, the Company designated 300 shares of its blank check preferred stock as Series A2 . The Series A2 ranks senior to the common stock and any subsequently created series of preferred stock that does not expressly rank pari passu with or senior to the Series A2 (the “Junior Stock”). The Series A2 can be converted at anytime and has a fixed conversion price of $0.00225 per common share. The Series A2 is entitled to minimum six years worth of dividends accruing at a rate of 8.5% per annum potentially increasing to 18% per annum under certain circumstances such as a significant decrease in the price of the Company’s common stock. Dividends are payable in cash or in shares of common stock valued at 85.0% of the closing market price of the Company’s common stock for any trading day following the issuance date of the Series A2. In the event of a liquidation, the Series A2 will be entitled to a payment of the Stated Value of $10,000 per share plus any accrued but unpaid dividends prior to any payments being made in respect of the Junior Stock. The holders of Series A2 do not have voting rights, except for shares in which have already been converted into shares of common stock.
	On January 8, 2014, the holder converted 10 Series A2 shares into 44,444,444 shares of common stock. In addition, under the terms of the Series A2 the holder was entitled to immediate payment of dividends on the $100,000 stated value of the Series A2 at an annual dividend rate of 18% rate, which is an increase over the stated 8.5% due to adjustments related to the decrease in the fair market value of the Company’s common stock, for a period of six years resulting in dividends payable of $108,000. The holder elected to convert the dividends to common stock based upon 85% of the closing market price as disclosed above resulting in a conversion price of $0.00017 with 635,294,118 common shares being issued. On the date of conversion, the fair market value of the dividend shares issued was $1,334,118 based upon the closing market price of the Company’s common stock. Thus, the Company recorded additional expense of $1,334,118 in connection with the dividend shares issued.
	On February 11, 2014, the holder converted 15 Series A2 shares into 66,666,666 shares of common stock. In addition, under the terms of the Series A2 the holder was entitled to immediate payment of dividends on the $150,000 stated value of the Series A2 at an annual dividend rate of 18% rate, which is an increase over the stated 8.5% due to adjustments related to the decrease in the fair market value of the Company’s common stock, for a period of six years resulting in dividends payable of $162,000. The holder elected to convert the dividends to common stock based upon 85% of the closing market price as disclosed above resulting in a conversion price of $0.00017 with 952,941,176 common shares to be issued. On the date of conversion, the fair market value of the dividend shares issued was $3,144,706 based upon the closing market price of the Company’s common stock. Thus, the Company recorded additional expense of $3,144,706 in connection with the dividend shares issued. During the three months ended March 31, 2015, the Company issued zero shares of common stock relieving the “Shares to Be Issued” account by $0. As of March 31, 2015, the Company has recorded within stockholders’ equity “Shares to Be Issued” of $869,906 as 263,607,842 common shares have not been delivered due to the 9.99% ownership limitation placed on the shareholders.
	On January 6, 2015, the holder converted 30 Series A2 shares into 133,333,333 shares of common stock. In addition, under the terms of the Series A2 the holder was entitled to immediate payment of dividends on the $300,000 stated value of the Series A2 at an annual dividend rate of 18% rate, which is an increase over the stated 8.5% due to adjustments related to the decrease in the fair market value of the Company’s common stock, for a period of six years resulting in dividends payable of $324,000, of which $51,140 had been accrued as of the date of conversion. The holder elected to convert the dividends to common stock based upon 85% of the closing market price as disclosed above resulting in a conversion price of $0.00034 with 952,941,176 common shares to be issued. On the date of conversion, the fair market value of the dividend shares issued was $476,471 based upon the closing market price of the Company’s common stock. Thus, the Company recorded additional expense of $425,331, fair market value of shares less dividends already accrued of $51,140, in connection with the dividend shares issued. During the three months ended March 31, 2015, the Company issued 496,274,510 shares of common stock relieving the “Shares to Be Issued” account by $481,471. As of March 31, 2015, the Company has recorded within stockholders’ equity “Shares to Be Issued” of $295,000 as 589,999,999 common shares have not been delivered due to the 9.99% ownership limitation placed on the shareholders.
	During the three months ended March 31, 2015 and 2014, the Company accrued dividends related to the Series A2 shares of $339,571 and $19,576, respectively. As of March 31, 2015 and December 31, 2014, accrued Series A2 dividends recorded within accounts payable and accrued liabilities on the accompanying balance sheet were $201,119 and $230,683, respectively.
	Series B Preferred Stock
	On February 28, 2013, the Company filed a Certificate of Designation of Series B Convertible Preferred Stock (“Series B”) with the Secretary of State of Nevada. Pursuant to the Series B Certificate of Designation, the Company designated 16,000,000 shares of its blank check preferred stock as Series B. The Series B ranks senior to the common stock and any subsequently created series of preferred stock that does not expressly rank pari passu with or senior to the Series B (the “Junior Stock”). The Series B cannot be converted into any other securities and does not receive dividends. Each share of Series B shall have voting rights equal to that of 2,000 shares of common stock. In the event of a liquidation, the Series B will be entitled to net assets on a pro rata basis.
	On March 1, 2013, the Company issued its Chief Executive Officer 16,000,000 shares of Series B Preferred Stock. The only rights the holder under the Series B has relates to voting control of the Company, which prior to the issuance the Chief Executive Officer, was the only officer and Board of Director member and already could make significant decisions, however, the Chief Executive Officer lacked voting control due to limited equity holdings in the Company. The issuance transferred voting control of the Company to the Chief Executive Officer.
	Series C Preferred Stock
	On March 27, 2014, the Company filed a Certificate of Designation of Series C Convertible Preferred Stock (“Series C”) with the Secretary of State of Nevada. Pursuant to the Series C Certificate of Designation, the Company designated 5,000 shares of its blank check preferred stock as Series C. The Series C ranks senior to the common stock and any subsequently created series of preferred stock that does not expressly rank pari passu with or senior to the Series C (the “Junior Stock”) and pari passu in rights to dividends and liquidation to the Series A2 and junior to all existing and future indebtedness of the Company. The Series C can be converted at anytime and has a fixed conversion price of $0.01 per common share. The Series C is entitled to minimum six years worth of dividends accruing at a rate of 8.5% per annum potentially increasing to 18% per annum under certain circumstances such as a significant decrease in the price of the Company’s common stock. Dividends are payable in cash or in shares of common stock valued at 85.0% of the closing market price of the Company’s common stock for any trading day following the issuance date of the Series C. In the event of a liquidation, the Series C will be entitled to a payment of the Stated Value of $10,000 per share plus any accrued but unpaid dividends prior to any payments being made in respect of the Junior Stock. The holders of Series C do not have voting rights, except for shares in which have already been converted into shares of common stock. During the three months ended March 31, 2015, the Company accrued dividends of $103,736 on the Series C. As of March 31, 2015 and December 31, 2014, total accrued dividends were $424,166 and $320,430, respectively.
	Common Stock
	2015 Issuances
	In 2014, the Company entered into an agreement to issue 50,000,000 shares of common stock valued at $135,000 based upon the closing market price of the Company’s common stock on the on the date of the agreement to a third party for sales and marketing services. The fair market value of the common stock issued was recorded as prepaid expenses and is being amortized over the contract period of one year. During the three months ended March 31, 2015, the Company amortized $22,500 to sales and marketing on the accompanying statement of operations. As of March 31, 2015, the remaining prepaid is $0. In addition, as of the date of this filing the common stock has not been issued and thus the value of $135,000 is recorded within stock to be issued on the accompanying balance sheet.
	During the three months ended March 31, 2015, the Company recorded compensation expense of $42,500 related to common stock to be issued under the Chief Executive Officer’s employment agreement. The shares were valued on date of the agreement being amortized over the term. Expected future compensation to be recorded during the years ended December 31; $127,500 for 2015 and $56,667 for 2016.
	During the three months ended March 31, 2015, the Company issued 251,166,667 shares of common stock in connection with a settlement agreement with the former Chief Executive Officer. The Company valued the shares of common stock at $125,583 based upon the closing market price of the Company’s common stock on the date of the agreement. The Company recorded a loss of $100,704 due to the excess fair market value of common stock issued in excess forgiven notes payable of $23,500 and accrued interest of $1,379.
	2014 Issuances
	During the three months ended March 31, 2015, the Company issued 1,754,386 shares of common stock valued at $4,737 based upon the closing market price of the Company’s common stock on the date of the agreement to a third party for the rights to future royalties related to Global Specialty Products, Inc.’s MicroRoasters brand.
	The Company amortized $30,000 of deferred compensation related to common stock granted during the three months ended March 31, 2014, which was being expensed over the service period.
	On January 27, 2014, the Company entered into a settlement with the prior management whereby prior management agreed to return 60,000,000 shares of the Company’s common stock previously issued to them for services rendered. In return, the Company has agreed to release prior management from any claims related to all costs deemed of a non-business nature. The Company accounted for the shares at their par value of $60,000 reducing common stock by that amount with the reclass to additional paid in capital. Upon return, the common stock was cancelled by the transfer agent and reflected in our calculation of weighted average shares for the three months ended March 31, 2015 as of the date of the agreement.
	Equity Line of Credit
	On February 28, 2014, the Company, entered into an Equity Line of Credit (the “Equity Line of Credit”) with Iconic Holdings, LLC (“Iconic”). Pursuant to the Equity Line of Credit, Iconic committed to purchase up to $2,000,000 of the Company’s common stock over twenty-four months from the first day following the effectiveness of a registration statement, subject to certain conditions.
	As soon as the Company has an effective registration statement in place, the Company may draw on the facility from time to time, as and when it determines appropriate in accordance with the terms and conditions of the related Equity Line of Credit. The Company has not yet filed a registration statement registering the shares and therefore, it has not yet sold any shares under the Equity Line of Credit. The purchase price will be 85% of the lowest trading price of the Company’s common stock during the five (5) consecutive trading day period beginning on the trading day immediately following the date of delivery of the applicable put notice. The maximum amount that the Company is entitled to put in on any one notice shall be any amount up to the greater of 1) the average of the trading dollar volume of the Company’s common stock during the ten (10) trading days preceding the request or 2) $100,000. Iconic is not obligated to purchase shares if its total number of shares beneficially held at that time would exceed 4.99% of the number of shares of the Company’s outstanding common stock as determined in accordance with Rule 13d-1 of the Securities Exchange Act of 1934, as amended. In addition, the Company is not permitted to draw on the facility unless there is an effective registration statement to cover the resale of the shares, which it does not currently have in place.
	Pursuant to the terms of a Registration Rights Agreement between the Company and Iconic, the Company is obligated to file a registration statement with the SEC to register the resale by Iconic of shares of the common stock underlying the Investment Agreement and it has not yet done so.
	In addition, under the terms of the Equity Line of Credit the Company was required to issue Iconic 10% of the total commitment amount in restricted common stock as a commitment fee. To date the Company issued 82,217,378 shares of common stock valued at $209,810 based upon the closing market price of the Company’s common stock on the date of the agreement. The Company initially recorded the value of such common stock as a deferred offering cost and expected to offset the amount against future proceeds received in connection with Equity Line of Credit. As of March 31, 2015, no proceeds have been received under the Equity Line of Credit. At December 31, 2014, the Company determined that future proceeds were not probable. Thus, the amount was written off as general and administrative expense at December 31, 2014.

Related_Party_Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2015
Related Party Transactions [Abstract]
Related Party Transactions	Note 6 - Related Party Transactions
	On March 28, 2013, the Company executed a 3% convertible note with a shareholder for $9,500 due within one year. The note is convertible into the Company’s common stock at a rate of $0.001 per share subject to various adjustments due to stock splits, change in control, etc. See Note 5 for discussion related to the conversion of this note into common stock.
	On November 29, 2012, the Company executed a 3% convertible note with a shareholder for $14,000 due within one year. The note is convertible into the Company’s common stock at the lesser of $0.001 per share (subject to various adjustments due to stock splits, change in control, etc) or a 20% discount to the current bid price on the date of conversion. See Note 5 for discussion related to the conversion of this note into common stock.
	As of March 31, 2015, amounts due to our Chief Executive Officer for salary payable recorded within Accounts Payable on the accompanying balance sheet were $43,319.

Subsequent_Events

Subsequent Events	3 Months Ended
	Mar. 31, 2015
Subsequent Events [Abstract]
Subsequent Events	Note 7 - Subsequent Events
	In accordance with ASC 855-10, the Company has analyzed its operations subsequent to March 31, 2015 through the date these financial statements were issued and has determined that it does not have any material subsequent events to disclose, other than the ones noted below, in these financial statements.
	Subsequent to quarter end, the Company received $50,000 in proceeds related to Series A2 Convertible Preferred stock.
	Subsequent to quarter end, the Company issued 590,000,000 shares of common stock in connection with conversions of Series A2. All of these shares were due under previous conversions of Series A2 into common stock.
	Subsequent to quarter end, the Company issued 319,963,261 shares of common stock in connection with conversions of convertible notes payable.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Going Concern	Going Concern
	The Company has limited working capital, has incurred losses in each of the past two years, and has not yet received material revenues from sales of products or services. These factors create substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern.
	The ability of RFMK to continue as a going concern is dependent on the Company generating cash from the sale of its common stock and/or obtaining debt financing and attaining future profitable operations. During the three months ended March 31, 2015, the Company funded operations through the receipt of $50,000 in net proceeds from convertible notes payable and $100,000 in connection with proceeds received in connection with the sale of Series A2 Convertible Preferred stock. As of March 31, 2015, the Company has subscriptions receivable from sales of Series A2 Convertible Preferred stock and Series C Convertible Preferred stock of $500,000 and $4,950,000, respectively. Subsequent to quarter end, the Company has received $50,000 in proceeds related to Series A2 Convertible Preferred stock. Management’s plans include collecting on the remaining sales of Series A2 Convertible Preferred stock and Series C Convertible Preferred stock, selling its equity securities and obtaining debt financing to fund its capital requirement and ongoing operations; however, there can be no assurance the Company will be successful in these efforts.
	The financial statements have been prepared on a going concern basis which contemplates the realization of assets and the settlement of liabilities in the normal course of business. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets and liabilities that might result from the outcome of this uncertainty.
Risks and Uncertainties	Risks and Uncertainties
	The Company has a limited operating history and has not generated significant revenues from our planned principal operations.
	The Company’s business and operations are sensitive to general business and economic conditions in the U.S. and worldwide. These conditions include short-term and long-term interest rates, inflation, fluctuations in debt and equity capital markets and the general condition of the U.S. and world economy. A host of factors beyond the Company’s control could cause fluctuations in these conditions, including the political environment and acts or threats of war or terrorism. Adverse developments in these general business and economic conditions, including through recession, downturn or otherwise, could have a material adverse effect on the Company’s financial condition and the results of its operations.
	The Company currently has minimal sales and limited marketing and/or distribution capabilities. The Company has limited experience in developing, training or managing a sales force and will incur substantial additional expenses if we decide to market any of our current and future products. Developing a marketing and sales force is also time consuming and could delay launch of our future products. In addition, the Company will compete with many companies that currently have extensive and well-funded marketing and sales operations. Our marketing and sales efforts may be unable to compete successfully against these companies. In addition, the Company has limited capital to devote sales and marketing.
	The Company’s industry is characterized by rapid changes in technology and customer demands. As a result, the Company’s products may quickly become obsolete and unmarketable. The Company’s future success will depend on its ability to adapt to technological advances, anticipate customer demands, develop new products and enhance our current products on a timely and cost-effective basis. Further, the Company’s products must remain competitive with those of other companies with substantially greater resources. The Company may experience technical or other difficulties that could delay or prevent the development, introduction or marketing of new products or enhanced versions of existing products. Also, the Company may not be able to adapt new or enhanced products to emerging industry standards, and the Company’s new products may not be favorably received. Nor may we have the capital resources to further the development of existing and/or new ones.
	The Company’s operations are subject to new innovations in product design and function. Significant technical changes can have an adverse effect on product lives. Design and development of new products are important elements to achieve and maintain profitability in the Company’s industry segment. The Company may be subject to federal, state and local environmental laws and regulations. The Company does not anticipate expenditures to comply with such laws and does not believe that regulations will have a material impact on the Company’s financial position, results of operations, or liquidity. The Company believes that its operations comply, in all material respects, with applicable federal, state, and local environmental laws and regulations
Use of Estimates	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Inventory	Inventory
	Inventory consists of two finished products, the CANNAcig Vapor Inhaler and the Cumulus Vapor Inhaler, which are valued at the lower of cost or market valuation under the first-in, first-out method of costing. In addition, deposits on inventory consist of monies advanced to the contract manufacturer in connection with the production of our new dry herbal vaporizer which expected to be put into production in early 2015 to be delivered in mid 2015.
	Product obsolescence may be caused by changes in technology, discontinuance of a product line, replacement products in the marketplace or other competitive situations. The Company maintains a reserve on inventories that are considered to be slow moving or obsolete, to reduce the inventory to their net estimated realizable value. Once specific inventory is written-down, the write-down is permanent until the inventory is physically disposed of.
Revenue Recognition	Revenue Recognition
	The Company generates revenue from the product sales of the CANNAcig Vapor Inhaler and the Cumulus Vapor Inhaler product sales of Bionic cigarettes revenue is recognized when the purchase is complete and shipment has occurred. Shipping and handling fees and costs incurred are included as an offset to general and administrative expenses. The amount of revenue received for shipping and handling is less than 5% of revenues for all periods presented. Sales tax collected from customers is not recorded as revenue. Sales tax collected is included in accounts payable until remitted to the taxing authorities.
Research and Development	Research and Development
	All research and development costs, including licensing costs, are charged to expense as incurred. In accordance with this policy, all costs associated with the design, development and testing of the Company’s products have been expensed as incurred.
Fair Value of Financial Instruments	Fair Value of Financial Instruments
	The Company follows Accounting Standards Codification (“ASC”) 825 Fair Value Measurements and Disclosures, except as it applies to the nonfinancial assets and nonfinancial liabilities subject to ASC 825. ASC 825 clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. As a basis for considering such assumptions, ASC 825 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:
	Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
	Level 2 - Include other inputs that are directly or indirectly observable in the marketplace.
	Level 3 - Unobservable inputs which are supported by little or no market activity.
	Fair-value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of March 31, 2015 and December 31, 2014. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values. These financial instruments include cash, prepaids, accounts payable, accrued liabilities, and convertible notes payable. Fair values for these items were assumed to approximate carrying values because of their short term nature or because they are payable on demand. As of March 31, 2015 and December 31, 2014, the Company’s derivative liabilities were considered Level 2. See Note 3 for discussion regarding the determination of the fair market value.
Earnings (loss) Per Share	Earnings (loss) Per Share
	Basic earnings (loss) per share are computed by dividing the net income (loss) by the weighted-average number of shares of common stock and common stock equivalents (primarily outstanding shares of convertible debt, preferred stock, options and warrants). Common stock equivalents represent the dilutive effect of the assumed exercise of the outstanding stock options and warrants, using the treasury stock method. The calculation of fully diluted earnings (loss) per share assumes the dilutive effect of the exercise of outstanding convertible debt, preferred stock, options and warrants at either the beginning of the respective period presented or the date of issuance, whichever is later. As of March 31, 2015 and 2014, the Company’s dilutive securities consisted of convertible notes payable and Series A1, Series A2 and Series C preferred stock. If the holders of the convertible notes payable, Series A1 Preferred Stock, Series A2 Preferred Stock and Series C Preferred Stock all converted, the Company would be in excess of their authorized shares. The outstanding dilutive securities have been excluded from the calculation of diluted net loss per share because the effect would have been anti-dilutive for the three months ended March 31, 2015 and 2014.

Convertible_Notes_Payable_and_1

Convertible Notes Payable and Derivative Liabilities (Tables)	3 Months Ended
	Mar. 31, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Convertible Notes Payable and Derivative Liabilities	The following are the weighted average variable used in determining the fair market value of the Company’s derivative liabilities:
	Date	9-Feb-15			10-Mar-15			31-Mar-15
	Closing stock price of common stock	$	0.0005		$	0.0004		$	0.0003
	Conversion price	$	0.0002		$	0.0001		$	0.0001
	Expected life in years		0.5			1			0.50 to 0.90
	Risk free rate		0.11	%		0.11	%		0.03	%
	Expected annual volatility		247	%		221	%		215% to 247%
	Dividend percentage		0	%		0	%		0	%

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Details Narrative) (USD $)	3 Months Ended		0 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 27, 2014
Summary of Significant Accounting Policies [Line Items]
Proceeds from convertible notes payable	$50,000	$100,000
Proceeds received from stock subscription	100,000	300,495
Percentage of revenue	5.00%
Series A2 Convertible Preferred stock [Member]
Summary of Significant Accounting Policies [Line Items]
Proceeds from convertible notes payable	100,000
Proceeds received from stock subscription	500,000
Proceeds from convertible preferred stock	50,000
Series C Preferred Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Proceeds received from stock subscription	4,950,000
Proceeds from convertible preferred stock			$5,000,000

Convertible_Notes_Payable_and_2

Convertible Notes Payable and Derivative Liabilities (Details Narrative) (USD $)	3 Months Ended		1 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Nov. 29, 2012	Mar. 31, 2015	Oct. 30, 2014	Feb. 28, 2014	Jan. 28, 2014	Jan. 31, 2014	Dec. 31, 2014	Mar. 28, 2013
Derivative [Line Items]
Proceeds from convertible notes payable	$50,000	$100,000
Common Stock, Capital Shares Reserved for Future Issuance	2,856,694,932			2,856,694,932
Debt Instrument, Unamortized Discount	27,100			27,100					25,767
Derivative Liability, Current	215,907			215,907					177,323
Derivative, Gain (Loss) on Derivative, Net, Total	11,416	-1,671,958
Accretion of Discount		10,000
Debt Conversion, Converted Instrument, Amount	89,882
Excess of derivative liabilities	124,041			124,041
Derivative Liabilities [Member]
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net, Total	-135,437	674,996
Convertible Notes Payable [Member]
Derivative [Line Items]
Due to Related Parties, Current	56,250			56,250
Debt Instrument, Face Amount			14,000							9,500
Proceeds from convertible notes payable	50,000
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger			20.00%
Debt Instrument, Unamortized Discount	27,100			27,100
Interest expense	54,917	24,018
Accretion of Discount	7,382
Debt Conversion, Converted Instrument, Amount	82,500
Stock Issued During Period, Shares, Conversion of Convertible Securities	831,755,454
Pyrenees Investments, LLC [Member]
Derivative [Line Items]
Due to Related Parties, Current							82,500
Debt Instrument, Face Amount	0			0					57,500
Iconic Holdings, LLC [Member]
Derivative [Line Items]
Debt Instrument, Face Amount	5,000			5,000					30,000
Iconic Holdings, LLC [Member] | Convertible Notes Payable [Member]
Derivative [Line Items]
Due to Related Parties, Current	25,000			25,000
Debt Instrument, Face Amount	230,000			230,000			82,500	165,000
Debt Instrument, Interest Rate, Stated Percentage	10.00%			10.00%			10.00%	10.00%
Debt Default Percentage Of Interest				20.00%		20.00%	20.00%
Proceeds from convertible notes payable					100,000	25,000		150,000
Debt Instrument, Interest Rate, Increase (Decrease)				150.00%		150.00%	150.00%
Debt Instrument, Maturity Date				10-Mar-15		28-Jan-15	24-Jan-15
Debt Instrument, Convertible, Stock Price Trigger						$0.00	$0.00
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger						50.00%	50.00%
Debt Instrument, Convertible, Beneficial Conversion Feature							82,500
Common Stock, Capital Shares Reserved for Future Issuance						250,000,000	250,000,000
Debt Instrument, Unamortized Discount	3,750			3,750		165,000	15,000
Proceeds from Related Party Debt						25,000
Debt Instrument, Convertible, Threshold Trading Days						20
Accretion of Discount				28,750		15,000
Iconic Holdings, LLC One [Member]
Derivative [Line Items]
Debt Instrument, Face Amount	$28,750			$28,750

Convertible_Notes_Payable_and_3

Convertible Notes Payable and Derivative Liabilities - Schedule of Convertible Notes Payable and Derivative Liabilities (Details) (Derivative Financial Instruments, Liabilities [Member], USD $)	0 Months Ended		3 Months Ended
	Mar. 10, 2015	Feb. 09, 2015	Mar. 31, 2015
Derivative [Line Items]
Closing stock price of common stock	$0.00	$0.00	$0.00
Conversion price	$0.00	$0.00	$0.00
Expected life in years	1 year	6 months
Risk free rate	0.11%	0.11%	0.03%
Expected annual volatility	221.00%	247.00%
Dividend percentage	0.00%	0.00%	0.00%
Minimum [Member]
Derivative [Line Items]
Expected life in years			6 months
Expected annual volatility			215.00%
Maximum [Member]
Derivative [Line Items]
Expected life in years			10 months 24 days
Expected annual volatility			247.00%

Subscriptions_Receivables_Deta

Subscriptions Receivables (Details Narrative) (USD $)	3 Months Ended		0 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Jan. 06, 2014	Mar. 27, 2014
Series A2 Notes [Member]
Subscriptions Receivables [Line Items]
Notes receivable, interest rate	1.00%
Notes receivable, related parties	$100,000	$250,000
Interest income	2,453	13,326
Subscription receivable		16,000
Series C Notes [Member]
Subscriptions Receivables [Line Items]
Number of notes receivable				100
Notes receivable, interest rate				1.00%
Notes receivable, related parties	4,950,000
Proceeds from related party	0	50,000
Series A2 Convertible Preferred stock [Member]
Subscriptions Receivables [Line Items]
Proceeds from issuance of convertible preferred stock	50,000
Stock issued during period, value, new issues			481,471
Series A2 Convertible Preferred stock [Member] | Ironridge Global IV, Ltd [Member]
Subscriptions Receivables [Line Items]
Proceeds from issuance of convertible preferred stock	450,000
Series C Preferred Stock [Member]
Subscriptions Receivables [Line Items]
Proceeds from issuance of convertible preferred stock				$5,000,000

Stockholders_Equity_Details_Na

Stockholders' Equity (Details Narrative) (USD $)	3 Months Ended		12 Months Ended	0 Months Ended						1 Months Ended		0 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Feb. 11, 2014	Jan. 27, 2014	Feb. 11, 2014	Jan. 08, 2014	Jan. 06, 2014	Oct. 05, 2012	Feb. 28, 2014	Feb. 28, 2013	Mar. 27, 2014	Sep. 06, 2011
Class of Stock [Line Items]
Preferred stock, shares authorized	90,000,000
Common stock shares authorized	20,000,000,000		20,000,000,000
Conversion of stock, amount converted	$300,000	$250,000
Common stock, capital shares reserved for future issuance	2,856,694,932
Interest payable	1,379
Common stock, shares, issued	6,539,404,848		4,960,208,217
Deferred compensation cost	30,000
Stock issued	135,000
Stock issued during period, shares, issued for employment agreement	42,500
Debt conversion, original debt, amount		82,500
Gain (loss) on sale of securities, net, total	-526,035	-4,478,824
Forgiveness of notes payable	23,500
Chief Executive Officer [Member]
Class of Stock [Line Items]
Number of shares issued for settlement agreement	251,166,667
Number of shares issued for settlement agreement, value	125,583
Gain (loss) on sale of securities, net, total	100,704
December 31, 2015 [Member]
Class of Stock [Line Items]
Compensation expenses	127,500
December 31, 2016 [Member]
Class of Stock [Line Items]
Compensation expenses	56,667
2015 Issuances [Member]
Class of Stock [Line Items]
Number of shares issued for sales and marketing services			135,000
Number of shares issued for sales and marketing services, shares			50,000,000
Deferred sales inducements, amortization expense	22,500
2014 Issuances [Member]
Class of Stock [Line Items]
Stock issued during period, shares, new issues	1,754,386
Stock issued during period, value, new issues	4,737
Common Stock [Member]
Class of Stock [Line Items]
Convertible preferred stock, shares issued upon conversion				952,941,176		952,941,176	635,294,118						30
Conversion of stock, shares issued				66,666,666
Share-based compensation arrangement by share-based payment award, options, forfeitures in period					60,000,000
Reduced par value during period					60,000
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Dividends payable, current			320,430
Series A1 Convertible Preferred stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	25,000,000		25,000,000										25,000,000
Preferred stock, value, issued	2,790		2,790
Series A2 Convertible Preferred stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	300		300						300
Convertible preferred stock, shares issued upon conversion								952,941,176
Conversion of stock, shares issued							44,444,444	133,333,333
Convertible preferred stock conversion price						$0.00	$0.00	$0.00	$0.00
Preferred stock, dividend rate, percentage						8.50%	8.50%	18.00%	8.50%
Preferred stock dividend rate percentage increase						18.00%	18.00%	8.50%	18.00%
Preferred stock dividend paid in stock percentage						85.00%	85.00%	85.00%	85.00%
Preferred stock, liquidation preference, value									10,000
Payment of dividends							100,000
Equity conversion amount								425,331
Dividends, preferred stock, total						150,000
Dividends payable, current				162,000		162,000		51,140
Conversion of stock, amount converted						3,144,706	1,334,118	476,471
Convertible preferred stock, shares reserved for future issuance	869,906
Common stock, capital shares reserved for future issuance	263,607,842
Number of preferred stock converted into common stock								133,333,333
Preferred stock conversion percentage						9.99%
Accounts payable and accrued liabilities	201,119		230,683
Preferred stock, value, issued
Stock issued during period, shares, new issues								496,274,510
Stock issued during period, value, new issues								481,471
Percentage of ownership	9.99%
Shares To Be Issued [Member] | Common Stock [Member]
Class of Stock [Line Items]
Stock issued during period, shares, new issues	0
Stock issued during period, value, new issues	0
Series A2 Convertible Preferred Stock One [Member]
Class of Stock [Line Items]
Convertible preferred stock, shares reserved for future issuance	295,000
Common stock, capital shares reserved for future issuance	589,999,999
Accrued dividends	339,571	19,576
Percentage of ownership	9.99%
Iconic Holdings, LLC [Member] | Line of Credit [Member]
Class of Stock [Line Items]
Long-term purchase commitment, amount										2,000,000
Threshold percentage of stock price trigger										85.00%
Volume average price of common stock										100,000
Percentage of stock outstanding										4.99%
Line of credit facility, commitment fee percentage										10.00%
Common stock, shares, issued										82,217,378
Dividends, preferred stock, stock										209,810
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	16,000,000		16,000,000
Preferred stock, designated shares											16,000,000
Preferred stock, voting rights											2,000
Preferred stock, value, issued	16,000		16,000
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	5,000		5,000									5,000
Convertible preferred stock conversion price												$0.01
Preferred stock, dividend rate, percentage												8.50%
Preferred stock dividend rate percentage increase												18.00%
Preferred stock dividend paid in stock percentage												85.00%
Dividends payable, current	424,166
Accrued dividends	103,736
Preferred stock, value, issued	$5		$5									$10,000

Related_Party_Transactions_Det

Related Party Transactions (Details Narrative) (USD $)	1 Months Ended
	Nov. 29, 2012	Mar. 31, 2015	Mar. 28, 2013
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Accrued salaries, current		$43,319
Convertible Notes Payable [Member]
Related Party Transaction [Line Items]
Debt instrument, interest rate, effective percentage	3.00%		3.00%
Debt instrument, face amount	$14,000		$9,500
Debt instrument, convertible, conversion price	$0.00		$0.00
Debt instrument, convertible, threshold percentage of stock price trigger	20.00%

Subsequent_Events_Details_Narr

Subsequent Events (Details Narrative) (USD $)	3 Months Ended
	Mar. 31, 2015
Subsequent Event [Member] | Convertible Notes Payable [Member]
Number of stock issued for conversion	319,963,261
Series A2 Convertible Preferred stock [Member]
Proceeds from convertible preferred stock	50,000
Series A2 Convertible Preferred stock [Member] | Subsequent Event [Member]
Proceeds from convertible preferred stock	50,000
Number of stock issued for conversion	590,000,000